PeptideDB

Betamipron 3440-28-6

Betamipron 3440-28-6

CAS No.: 3440-28-6

Betamipron is a chemical compound that may be used in combination with Panipenem to inhibit the uptake of Panipenem into
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Betamipron is a chemical compound that may be used in combination with Panipenem to inhibit the uptake of Panipenem into the renal tubules and prevent nephrotoxicity.

Physicochemical Properties


Molecular Formula C10H11NO3
Molecular Weight 193.1992
Exact Mass 193.074
CAS # 3440-28-6
PubChem CID 71651
Appearance White to off-white solid powder
Density 1.227 g/cm3
Boiling Point 469.2ºC at 760 mmHg
Melting Point 132 °C
Flash Point 237.6ºC
Index of Refraction 1.557
LogP 1.282
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 4
Heavy Atom Count 14
Complexity 209
Defined Atom Stereocenter Count 0
InChi Key CWXYHOHYCJXYFQ-UHFFFAOYSA-N
InChi Code

InChI=1S/C10H11NO3/c12-9(13)6-7-11-10(14)8-4-2-1-3-5-8/h1-5H,6-7H2,(H,11,14)(H,12,13)
Chemical Name

3-benzamidopropanoic acid
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Additional Infomation Betamipron is an organonitrogen compound and an organooxygen compound. It is functionally related to a beta-amino acid.

Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~517.60 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (12.94 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (12.94 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (12.94 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 5.1760 mL 25.8799 mL 51.7598 mL
5 mM 1.0352 mL 5.1760 mL 10.3520 mL
10 mM 0.5176 mL 2.5880 mL 5.1760 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.